Growing placebo response rate: the problem in recent therapeutic trials?

Author: MatuzasW, ThompsonP M, UhlenhuthE H, WarnerT D

Paper Details 
Original Abstract of the Article :
Recently the development of several promising new compounds for anxiety and depression was discontinued because of difficulty demonstrating therapeutic effects. This article explores alternatives to "increasing placebo response rate" as explanations. We reanalyzed a study of 81 panic patients treate...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/9133749

データ提供:米国国立医学図書館(NLM)

Growing Placebo Response Rate: A Shifting Landscape in the Desert of Therapeutic Trials

Greetings from Dr. Camel, your guide through the ever-changing desert of therapeutic research. This article explores the challenges of demonstrating therapeutic effects in clinical trials, particularly in the context of anxiety and depression. The researchers investigate the potential role of placebo response rate and its impact on the interpretation of trial results. Their analysis sheds light on the complexities of designing and interpreting clinical trials, offering valuable insights into the ever-evolving landscape of therapeutic research.

Placebo Response Rate: A Shifting Sand Dune in the Desert

The researchers reanalyze a study of 81 panic patients treated with placebo, alprazolam, or imipramine, examining the effect of baseline pathology and treatment on various aspects of panic disorder. Their analysis suggests that the regression of endpoint on baseline number of spontaneous panic attacks differed among treatment groups, with lower slopes for the more active compounds. This indicates that patients with higher baseline panic attack frequency may benefit more from active treatment. It's like witnessing a shifting sand dune in the desert - where the dynamics of treatment response can vary depending on the initial state of the system.

The Desert of Therapeutic Research: Navigating the Shifting Sands

This article highlights the importance of carefully considering the factors that can influence placebo response rate in clinical trials. It emphasizes the need for rigorous study designs and comprehensive analyses to ensure accurate interpretation of results. Just like navigating a desert landscape, where the terrain is constantly shifting, therapeutic research requires a flexible and adaptive approach to effectively address the complexities of human health and disease.

Dr. Camel's Conclusion

The desert of therapeutic research is vast and complex, with many challenges and uncertainties. This article provides valuable insights into the dynamics of placebo response rate, reminding us that the landscape of therapeutic research is constantly evolving. As we continue to explore this desert, we must be vigilant in our pursuit of reliable and effective treatments, ensuring that our research methods are robust and our interpretations are sound.

Date :
  1. Date Completed 1997-05-29
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

9133749

DOI: Digital Object Identifier

9133749

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.